Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Total Liabilities: 2015-2025

Historic Total Liabilities for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $78.0 million.

  • Cryo Cell International's Total Liabilities rose 759.67% to $78.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $78.0 million, marking a year-over-year increase of 759.67%. This contributed to the annual value of $77.9 million for FY2024, which is 780.83% up from last year.
  • Latest data reveals that Cryo Cell International reported Total Liabilities of $78.0 million as of Q3 2025, which was up 759.67% from $80.0 million recorded in Q2 2025.
  • Cryo Cell International's 5-year Total Liabilities high stood at $107.0 million for Q1 2021, and its period low was $50.6 million during Q1 2022.
  • Its 5-year average for Total Liabilities is $69.5 million, with a median of $69.8 million in 2023.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 11083.64% in 2021, then tumbled by 5273.26% in 2022.
  • Quarter analysis of 5 years shows Cryo Cell International's Total Liabilities stood at $56.5 million in 2021, then grew by 17.59% to $66.4 million in 2022, then increased by 8.79% to $72.3 million in 2023, then increased by 7.81% to $77.9 million in 2024, then rose by 0.14% to $78.0 million in 2025.
  • Its last three reported values are $78.0 million in Q3 2025, $80.0 million for Q2 2025, and $79.0 million during Q1 2025.